Jack Stover Insider Profile
11 Followers
Jack Stover, CEO at Profusa, holds 302.06K shares in Profusa (Ticker: PFSA), holds 6.17K shares in Traws Pharma (Ticker: TRAW), holds 30.27K shares in Interpace Diagnostics Group (Ticker: IDXG). Most recently, Jack Stover Bought ― shares of Profusa on Aug 19, 2026 for an estimated value of $1.29M.
Jack Stover has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jack Stover holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Jack Stover
Jack Stover's Trading History
Profusa
Aug 19, 2026
CEO
Informative Buy
1.29M
$1.65M
Traws Pharma
Dec 16, 2025
Director
Uninformative Buy
―
$3.27K
Interpace Diagnostics Group
Apr 06, 2020
Former officer and director
Uninformative Buy
―
$46.07K
Antares Pharma
―
―
―
$1.55M
List of latest transactions for each holding click on a transaction to see Jack Stover's performance on stock
You May Also Like
Jack Stover insider profile FAQ
What is the percentage of profitable transactions made by Jack Stover?
The percentage of profitable transactions made by Jack Stover is ―.
What is the average return per transaction made by Jack Stover?
The average return per transaction made by Jack Stover is ―.
What stocks does Jack Stover hold?
Jack Stover holds: PFSA, TRAW, IDXG, ATRS stocks.
What was Jack Stover’s latest transaction?
Jack Stover latest transaction was an Informative Buy of $1.29M.
What was Jack Stover's most profitable transaction?
Jack Stover’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Jack Stover's role in Profusa?
Jack Stover's role in Profusa is CEO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.